THURSDAY, June 27, 2024 -- For adults with obesity, without diabetes, combining exercise with the glucagon-like peptide-1 receptor agonist (GLP-1 RA),...
Vous n'êtes pas connecté
MONDAY, June 17, 2024 -- Most patients taking survodutide, a dual agonist of glucagon receptor and glucagon-like peptide-1 (GLP-1) receptor, experience significant improvement in metabolic dysfunction-associated steatohepatitis (MASH) without...
THURSDAY, June 27, 2024 -- For adults with obesity, without diabetes, combining exercise with the glucagon-like peptide-1 receptor agonist (GLP-1 RA),...
Steatotic (fatty) liver disease is on the rise in many countries around the world. A rise in steatotic liver disease comes with an increase in the...
FRIDAY, June 28, 2024 -- Metabolic surgery is associated with significantly lower risk of major adverse cardiovascular events (MACE) compared with...
Can insulin resistance cause fatty liver? Yes, high predisposition to insulin resistance leads to fatty liver in Indians.
MONDAY, June 17, 2024 -- In postmenopausal women, chronic kidney disease (CKD) may be associated with tooth loss, according to a study published...
MONDAY, June 24, 2024 -- Childhood risk factors are associated both directly and indirectly to adult cardiovascular disease (CVD), according to a...
MONDAY, June 24, 2024 -- Automated quantitative tests for NT-proBNP and interleukin 1 receptor-like 1 (IL-1 RL1) can identify high-risk congenital...
WEDNESDAY, June 19, 2024 -- Increasing physical activity during childhood may independently lower the risk for liver disease in young adulthood,...
Being highly predisposed to insulin resistance puts Indians at a higher risk of developing non-alcoholic fatty liver disease (NAFLD), suggest health...
FRIDAY, June 21, 2024 -- For patients with hypertension, angiotensin receptor blockers (ARBs) are associated with a reduced incidence of epilepsy...